Rivastigmine in the treatment of alcohol-induced persisting dementia.
A case of Alcohol-Induced Persisting Dementia (AIPD) in a 62-year-old man is presented. His progress on treatment with the acetylcholinesterase inhibitor, rivastigmine, is followed. The significant improvement observed suggests that AIPD may be a new indication for this class of drug.
Gibson
R C
RC
Department of Community Health and Psychiatry, Section of Psychiatry, University of the West Indies, Kingston 7, Jamaica, West Indies.
Barnaby
L
L
D020268:Alcohol-Induced Disorders, Nervous System / Q000188:drug therapy*; D000544:Alzheimer Disease / Q000188:drug therapy*; D002219:Carbamates / Q000627:therapeutic use*; D002492:Central Nervous System Depressants / Q000009:adverse effects*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D000431:Ethanol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D048448:Phenylcarbamates; D000068836:Rivastigmine
D002219:Carbamates; D002492:Central Nervous System Depressants; D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D000431:Ethanol; D000068836:Rivastigmine